Bing Xu

10PUBLICATIONS
47CO-AUTHORS
Haematological tumoursMolecular targetsPredictive and prognostic markersImmunogenetics (incl. genetic immunology)Medical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|May 07, 2026
Rewiring NADH Metabolism Through NQO1-Mediated Redox Cycling for Targeted Follicular Lymphoma Therapy.

|Mar 24, 2026
Dual targeting of PI3Kδ and PPARα enhances antitumor activity via FoxO1 activation in follicular lymphoma.

Wenqin Wang, Hui Zhou, Shuangxiong Tan

|Oct 06, 2025
Combination of HDAC inhibitor and PI3K inhibitor suppresses autophagy and induces apoptosis via cytoplasmic IκBα stabilization in p53-mutant diffuse large B-cell lymphoma.

Jingwei Yao, Mengqi Li, Yuelong Jiang

|Sep 27, 2024
Time to lymphoma treatment within 24 months in 'watch and wait' follicular lymphoma is associated with inferior outcomes: A multicentre analysis.

Jing Liu, Fenghua Gao, Tingting Zhang

|Sep 25, 2024
Combinations of HDAC Inhibitor and PPAR Agonist Induce Ferroptosis of Leukemic Stem Cell-like Cells in Acute Myeloid Leukemia.

Hui Zhou, Dongmei Qin, Chendi Xie

|Dec 06, 2023
Expression of interferon regulatory factor family and its prognostic value in acute myeloid leukemia.

Jiawei Zeng, Jingwei Yao, Yong Zhou

Pageof 2

Frequent Collaborators

3 joint publications

Jie Zha

1 joint publications

Zijun Y Xu-Monette

1 joint publications

Yong Li

1 joint publications

Thomas Snyder